doxorubicin hydrochloride

This medicinal product is a cytotoxic antibiotic used in adults and children for the treatment of various types of tumors, including those of the breast, lung, bladder, thyroid, ovary, bone, soft tissue, nervous tissue, kidneys, and blood (leukemias and lymphomas).

Form: solution for injection, powder and solvent

ATC: L01DB01

Manufacturer: PFIZER ITALIA S.R.L.

It is an antitumoral agent used to treat breast cancer (in patients at risk of heart problems), ovarian cancer, and multiple myeloma (in combination with bortezomib). It is also used to improve Kaposi's sarcoma by reducing its size and symptoms.

Form: solution for infusion, concentrate

ATC: L01DB01

Manufacturer: BAXTER HOLDING BV

It is an antitumoral agent used for the treatment of breast cancer (in patients at risk of heart problems), ovarian cancer, and multiple myeloma (in combination with bortezomib). It is also used to improve the symptoms of Kaposi's sarcoma.

Form: concentrate for dispersion for infusion

ATC: L01DB01

Manufacturer: BAXTER HOLDING BV

It is used for the treatment of various forms of cancer, including breast cancer, sarcoma, stomach or intestinal tumors, lung cancer, lymphoma, leukemia, thyroid cancer, ovarian and endometrial cancer, bladder cancer, advanced neuroblastoma, Wilms tumor (kidney cancer in children), and myeloma.

Form: solution for infusion, concentrate

ATC: L01DB01

Manufacturer: ACCORD HEALTHCARE, S.L.U.

This medicine belongs to the anthracycline class and is used to treat several types of cancer, including breast, bladder, lung, bone, blood, lymphatic system, bone marrow, thyroid, soft tissue, ovarian, or uterine cancer, as well as certain kidney or nerve tumors in children. It may also be used in combination with other anticancer drugs.

Form: solution for infusion, concentrate

ATC: L01DB01

Manufacturer: Eugia Pharma (Malta) Limited

This drug is an antineoplastic used to treat several types of cancer, including breast cancer, osteosarcoma (bone cancer), soft tissue sarcoma, lung carcinoma, lymphomas, certain leukemias, multiple myeloma, uterine cancer, thyroid tumors, some bladder tumors, recurrent ovarian cancer, and certain pediatric tumors such as Wilms' tumor and neuroblastoma.

Form: solution for infusion, concentrate

ATC: L01DB01

Manufacturer: TEVA ITALIA S.R.L.

It is an antitumoral agent used for the treatment of breast cancer (in patients at risk of heart problems), ovarian cancer, multiple myeloma (in combination with bortezomib), and to improve the conditions of Kaposi's sarcoma.

Form: concentrate for dispersion for infusion

ATC: L01DB01

Manufacturer: ACCORD HEALTHCARE, S.L.U.